Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Monte Rosa Therapeutics, Inc
AstraZeneca
Boundless Bio, Inc.
National Cancer Institute (NCI)
Pfizer
Klus Pharma Inc.
Theratechnologies
Cybrexa Therapeutics
Carisma Therapeutics Inc
Salubris Biotherapeutics Inc